Markomed d.o.o. was founded in 2007 and has become one of the leading distributors in the field of anesthesia and intensive care with a wide portfolio of products for hemodynamic monitoring, preparation and administration of infusion therapy, administration of spinal and regional anesthesia, endoscopy and bronchoscopy, thoracic drainage, neurosurgery, defibrillation and resuscitation.
From the very beginning, a quality system based on the ISO 9001:15 standard was established, and the company has recently complied with the requirements of the ISO 13485:16 standard for medical products.
While considering the further development of the company, and respecting the needs of our customers, in 2022 Markomed d.o.o. made a strategic decision on the production of a new product – user applied labels for syringes containing drugs in accordance with international ISO 26825:2020 standard.
In 2022 Markomed d.o.o. started researching and developing products and finding a reliable partner for the production of MarkTag® user applied labels, and, in early 2023, protected the MarkTag® trademark at the State Institute for Intellectual Property. The first batch of MarkTag® labels, preceded by a successful product certification by TÜV NORD Adriatic d.o.o. certification body, was successfully launched in April 2023. At the same time, it is important to point out that certification by a third, independent certification body is not a legal requirement, but the company’s desire to provide its customers and clients with a product that fully meets international standards and is an indicator of exceptional product quality.
Markomed d.o.o.
MBS: 080630293
MB: 2307057
OIB: 23340771306
Trg braće Radić 3
21000 Split
Croatia
Tel. 00 385 0 21355112
Fax. 00 385 021355095
You can send us a message by email: info@marktag.eu or using contact form.
Please send us your enquiry and we'll make sure the most appropriate person gets back to you as soon as possible.